Trontinemab
CAS No. 2568868-35-7
Trontinemab ( —— )
产品货号. M37269 CAS No. 2568868-35-7
Trontinemab 是一种双特异性人源 IgG1-κ 抗体,靶向淀粉样蛋白 β A4 前体蛋白 (APP) 和转铁蛋白受体 p90, CD71 (TFRC)。Trontinemab 可用于阿兹海默症的研究。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Trontinemab
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Trontinemab 是一种双特异性人源 IgG1-κ 抗体,靶向淀粉样蛋白 β A4 前体蛋白 (APP) 和转铁蛋白受体 p90, CD71 (TFRC)。Trontinemab 可用于阿兹海默症的研究。
-
产品描述Trontinemab is a bispecific and humanized IgG1-κ antibody, targeting to amyloid beta A4 precursor protein (APP) and transferrin receptor, p90, CD71 (TFRC). Trontinemab can be used for research on Alzheimer disease (AD).
-
体外实验——
-
体内实验——
-
同义词——
-
通路Membrane Transporter/Ion Channel
-
靶点Beta Amyloid
-
受体Beta Amyloid
-
研究领域——
-
适应症——
化学信息
-
CAS Number2568868-35-7
-
分子量
-
分子式——
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
-
AC 253
Amylin (AMY3) receptor antagonist. Inhibits andrenomedulin-stimulated cAMP production in vitro. Protects against oligomeric Aβ-induced increase in intracellular Ca2+, activation of PKA, MAPK, Akt and cFOS and cell death in neuronal cell culture. Blocks electrophysiological effects of Aβ in vitro. Cyclic AC 253 also available.
-
β-Amyloid 29-40
β-Amyloid (29-40) is a fragment of Amyloid-β peptide.Alzheimer's beta amyloid peptide (29-40/42) C-terminal fragments have physical and chemical properties related to those of fusion peptides of viral proteins. The fusion of liposomes can be induced by these peptides in vitro.
-
β-Amyloid 12-20
β-Amyloid (12-20) is a peptide fragment of β-Amyloid.Thsis peptide contain the amino acid residues VFF at position (18-20), suggesting that this triad has amnestic effects.
021-51111890
购物车()
sales@molnova.cn

